biotech.today
All Modalities
TherapeuticsEarly Stage

Microbiome Therapeutics

Therapies that modulate the human microbiome to treat disease. Includes live biotherapeutics, engineered bacteria, and microbiome-derived metabolites targeting conditions from C. diff infections to inflammatory bowel disease.

Key Companies

Ferring (Rebyota)Seres TherapeuticsVedanta BiosciencesFinch Therapeutics

AI Tools